These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19936193)

  • 1. Mast cells: pivotal players in cardiovascular diseases.
    Bot I; van Berkel TJ; Biessen EA
    Curr Cardiol Rev; 2008 Aug; 4(3):170-8. PubMed ID: 19936193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mast cells in atherosclerosis.
    Wezel A; Quax PH; Kuiper J; Bot I
    Hamostaseologie; 2015; 35(2):113-20. PubMed ID: 25377048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells and degradation of pericellular and extracellular matrices: potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques.
    Kovanen PT
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):857-61. PubMed ID: 17956232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice.
    Bot I; de Jager SC; Zernecke A; Lindstedt KA; van Berkel TJ; Weber C; Biessen EA
    Circulation; 2007 May; 115(19):2516-25. PubMed ID: 17470698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation.
    Lagraauw HM; Westra MM; Bot M; Wezel A; van Santbrink PJ; Pasterkamp G; Biessen EA; Kuiper J; Bot I
    Atherosclerosis; 2014 Jul; 235(1):196-203. PubMed ID: 24858338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast Cells in Cardiovascular Disease: From Bench to Bedside.
    Hermans M; Lennep JRV; van Daele P; Bot I
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells in atherosclerotic cardiovascular disease - Activators and actions.
    Kovanen PT; Bot I
    Eur J Pharmacol; 2017 Dec; 816():37-46. PubMed ID: 29032103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of mast cells on cardiovascular diseases.
    Kritikou E; Kuiper J; Kovanen PT; Bot I
    Eur J Pharmacol; 2016 May; 778():103-15. PubMed ID: 25959384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
    Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
    Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Number of Mast Cells in Atherosclerotic Lesions Correlates with the Presence of Myeloid but not Plasmacytoid Dendritic Cells as well as Pro-inflammatory T Cells.
    Rohm I; Sattler S; Atiskova Y; Kretzschmar D; Pistulli R; Franz M; Jung C; Mall G; Kronert T; Schulze PC; Yilmaz A
    Clin Lab; 2016 Dec; 62(12):2293-2303. PubMed ID: 28164558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen and related extracellular matrix proteins in atherosclerotic plaque development.
    Shami A; Gonçalves I; Hultgårdh-Nilsson A
    Curr Opin Lipidol; 2014 Oct; 25(5):394-9. PubMed ID: 25137612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No long-lasting or intermittent mast cell activation in acute coronary syndromes.
    van Haelst PL; Timmer JR; Crijns HJ; Kauffman HF; Gans RO; van Doormaal JJ
    Int J Cardiol; 2001 Mar; 78(1):75-80. PubMed ID: 11259815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells in atherosclerosis.
    Bot I; Biessen EA
    Thromb Haemost; 2011 Nov; 106(5):820-6. PubMed ID: 21866302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary hypersensitivity disorder: the Kounis syndrome.
    Kounis NG
    Clin Ther; 2013 May; 35(5):563-71. PubMed ID: 23490289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-apoptotic serpins as therapeutics in cardiovascular diseases.
    Kuiper J; Quax PH; Bot I
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):111-22. PubMed ID: 23987999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular role of mast cells in atherosclerotic cardiovascular disease.
    Kelley JL; Chi DS; Abou-Auda W; Smith JK; Krishnaswamy G
    Mol Med Today; 2000 Aug; 6(8):304-8. PubMed ID: 10904247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis.
    Kritikou E; Depuydt MAC; de Vries MR; Mulder KE; Govaert AM; Smit MD; van Duijn J; Foks AC; Wezel A; Smeets HJ; Slütter B; Quax PHA; Kuiper J; Bot I
    Cells; 2019 Apr; 8(4):. PubMed ID: 30970663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions.
    Centurión OA
    Cardiovasc Revasc Med; 2016 Mar; 17(2):119-28. PubMed ID: 26905055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture.
    Lindstedt KA; Kovanen PT
    Curr Opin Lipidol; 2004 Oct; 15(5):567-73. PubMed ID: 15361793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.